<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(9)</volume><submitter>Irfandi R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study was carried out to synthesize a new complex of Fe(II) with isoleucine dithiocarbamate ligand and to determine its potential as an anticancer and antiviral agent for SARSCOV-2.&lt;h4>Methods&lt;/h4>The synthesized complexes were then characterized by UV-vis and FT-IR spectroscopy and their melting points. The value of the conductivity of the complex compound is also determined. Anti-cancer activity was tested in vitro and molecular docking. Its potential as an antiviral against SARSCOV-2 was also carried out by molecular docking. Pharmacokinetics/ADMET properties were also carried out on the complex.&lt;h4>Result&lt;/h4>Spectral results showed the successful synthesis of Fe(II) isoleucine dithiocarbamate complex. The complex produced UV-vis spectra at 268 and 575 nm, and t</pubmed_abstract><journal>Asian Pacific journal of cancer prevention : APJCP</journal><pagination>3113-3123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9810283</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A New Complex Design of Fe (II) Isoleucine Dithiocarbamate as a Novel Anticancer and Antivirus against SARSCOV-2 (COVID-19).</pubmed_title><pmcid>PMC9810283</pmcid><pubmed_authors>Ahmad A</pubmed_authors><pubmed_authors>Prihantono P</pubmed_authors><pubmed_authors>Santi S</pubmed_authors><pubmed_authors>Riswandi R</pubmed_authors><pubmed_authors>Irfandi R</pubmed_authors><pubmed_authors>Wijaya RI</pubmed_authors><pubmed_authors>Raya I</pubmed_authors><pubmed_authors>Tirto Sari DR</pubmed_authors><pubmed_authors>Fudholi A</pubmed_authors><pubmed_authors>Jarre S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A New Complex Design of Fe (II) Isoleucine Dithiocarbamate as a Novel Anticancer and Antivirus against SARSCOV-2 (COVID-19).</name><description>&lt;h4>Background&lt;/h4>This study was carried out to synthesize a new complex of Fe(II) with isoleucine dithiocarbamate ligand and to determine its potential as an anticancer and antiviral agent for SARSCOV-2.&lt;h4>Methods&lt;/h4>The synthesized complexes were then characterized by UV-vis and FT-IR spectroscopy and their melting points. The value of the conductivity of the complex compound is also determined. Anti-cancer activity was tested in vitro and molecular docking. Its potential as an antiviral against SARSCOV-2 was also carried out by molecular docking. Pharmacokinetics/ADMET properties were also carried out on the complex.&lt;h4>Result&lt;/h4>Spectral results showed the successful synthesis of Fe(II) isoleucine dithiocarbamate complex. The complex produced UV-vis spectra at 268 and 575 nm, and t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-05T11:23:48.153Z</modification><creation>2025-04-05T11:23:48.153Z</creation></dates><accession>S-EPMC9810283</accession><cross_references><pubmed>36172674</pubmed><doi>10.31557/APJCP.2022.23.9.3113</doi></cross_references></HashMap>